Experimentally-determined fitness landscape of beta-lactamase inhibitory protein
实验确定的 β-内酰胺酶抑制蛋白的适应性景观
基本信息
- 批准号:8656369
- 负责人:
- 金额:$ 4.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-01 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAmino Acid SubstitutionAmino AcidsAmpicillinAntibiotic ResistanceAntibiotic TherapyAntibioticsBacterial InfectionsBase PairingBiological ProcessBiologyCommunicable DiseasesCoupledDNADNA SequenceDataData SetDiseaseEnzymesEscherichia coliEvolutionGene MutationGenerationsGenesGenetic CodeGenetic VariationGenomicsHereditary DiseaseHigh-Throughput Nucleotide SequencingKnowledgeLaboratoriesLibrariesMedicalMethodsMinimum Inhibitory Concentration measurementModelingMutagenesisMutationNatureOrganismOutcomes ResearchPreventionProtein EngineeringProtein InhibitionProteinsPublic HealthRelative (related person)ResearchShapesSite-Directed MutagenesisSorting - Cell MovementSystemTechnologyTestingTimeVariantbasebeta-Lactamasecommon treatmentfitnessgenetic selectionimprovedinfectious disease treatmentinhibitor/antagonistmembermicrochipthree dimensional structure
项目摘要
DESCRIPTION (provided by applicant): The proposed project seeks to overcome a major barrier in the study of mutations in evolution by experimentally determining the distribution of fitness effects of every nearest neighbor variant (variants that differ from the wildtype sequence by a single base pair mutation) of the gene encoding beta- lactamase inhibitory protein (BLIP). Specifically, this research aims to create a library of every nearest neighbor variant of BLIP on the DNA and on the amino acid level and to quantify the fitness of these variants. Library creation will be accomplished using Kunkle mutagenesis, a site-directed mutagenesis method that can produce a high percentage of DNA with the desired mutations. Fitness will be characterized based on the ability of BLIP variants to inhibit TEM-1 beta-lactamase (an antibiotic resistance enzyme that hydrolyzes beta-lacam antibiotics, such as ampicillin). E. coli will be transformed with the BLIP library and a unique band-pass selection system will be utilized to separate the library into bins based on the minimal inhibitory concentration (MIC) for ampicillin. Because the minimum inhibitory concentration inversely correlates to the function of BLIP, the library will be sorted into sub-libraries that reflect relative fitness. High-throughput sequencing technology will be used to determine the DNA sequence of every library member. In this way, a complete fitness distribution due to single base pair mutations for the entire gene wil be determined. This result will address a number of questions about mutations, including the contributions of synonymous versus non-synonymous mutations, and how fitness effects are distributed in the linear sequence and in the three-dimensional structure of BLIP. This knowledge of mutational effects has the potential to significantly improve understanding in the fields of evolutionary biology, protein engineering, and medical genomics. The outcomes of this research will also be of medical significance owing to the increased understanding of an antibiotic resistance inhibitor and the possibility of finding an improved BLIP variant.
描述(由申请人提供):拟议的项目旨在通过实验确定编码编码基因β-氨基氨基酰胺酶抑制性蛋白(BLIP)的每个最近邻居变体的适应性效应(与野生型序列不同的变体(与单个碱基对突变不同)的适应性效应(与WildType序列不同),以克服进化过程中的主要障碍。具体而言,这项研究旨在创建一个在DNA和氨基酸水平上的Blip的每个最近邻居变体的库,并量化这些变体的适应性。将使用Kunkle诱变(一种定点诱变方法)来实现库的创建,该方法可以产生具有所需突变的高百分比DNA。适合度将根据BLIP变体抑制TEM-1β-内酰胺酶的能力(一种水解β-酰胺抗生素(如氨苄青霉素)的抗生素耐药性酶)的能力。大肠杆菌将使用BLIP库进行转换,并将利用独特的带通路选择系统将库基于氨苄西林的最小抑制浓度(MIC)将库分开。由于最小抑制浓度与BLIP的功能呈竞相相关,因此该库将被分类为反映相对适应性的亚纤维。高通量测序技术将用于确定每个库成员的DNA序列。这样,可以确定整个基因的单基对突变引起的完整适应性分布。该结果将解决有关突变的许多问题,包括同义词与非同义突变的贡献,以及如何以线性序列和BLIP的三维结构分布适应性效应。这种对突变效应的知识有可能显着提高进化生物学,蛋白质工程和医学基因组学领域的理解。由于对抗生素耐药性抑制剂的了解增加以及发现改善的BLIP变体的可能性,这项研究的结果也将具有医学意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Courtney Elaine Gonzalez其他文献
Courtney Elaine Gonzalez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Courtney Elaine Gonzalez', 18)}}的其他基金
Experimentally-determined fitness landscape of beta-lactamase inhibitory protein
实验确定的 β-内酰胺酶抑制蛋白的适应性景观
- 批准号:
8486252 - 财政年份:2012
- 资助金额:
$ 4.27万 - 项目类别:
Experimentally-determined fitness landscape of beta-lactamase inhibitory protein
实验确定的 β-内酰胺酶抑制蛋白的适应性景观
- 批准号:
8320625 - 财政年份:2012
- 资助金额:
$ 4.27万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
- 批准号:32371616
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
- 批准号:32300624
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
- 批准号:52377215
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Small Molecule Therapeutics for Sickle Cell Anemia
镰状细胞性贫血的小分子疗法
- 批准号:
10601679 - 财政年份:2023
- 资助金额:
$ 4.27万 - 项目类别:
High-throughput thermodynamic and kinetic measurements for variant effects prediction in a major protein superfamily
用于预测主要蛋白质超家族变异效应的高通量热力学和动力学测量
- 批准号:
10752370 - 财政年份:2023
- 资助金额:
$ 4.27万 - 项目类别:
High-throughput functional analysis and clinical relevance of all possible variants of a gene
基因所有可能变异的高通量功能分析和临床相关性
- 批准号:
10601908 - 财政年份:2023
- 资助金额:
$ 4.27万 - 项目类别:
Mechanistic Studies of Viral Host Cell Recognition and Entry and their Implication for Protein Design of Molecular Delivery Devices
病毒宿主细胞识别和进入的机制研究及其对分子递送装置蛋白质设计的意义
- 批准号:
10527903 - 财政年份:2022
- 资助金额:
$ 4.27万 - 项目类别: